145 related articles for article (PubMed ID: 1838269)
1. ASCO supports government report: "Off-label drugs: reimbursement policies constrain physicians in choice of cancer therapies".
Oncology (Williston Park); 1991 Oct; 5(10):29-30, 33. PubMed ID: 1838269
[No Abstract] [Full Text] [Related]
2. Does reimbursement influence chemotherapy treatment for cancer patients?
Jacobson M; O'Malley AJ; Earle CC; Pakes J; Gaccione P; Newhouse JP
Health Aff (Millwood); 2006; 25(2):437-43. PubMed ID: 16522584
[TBL] [Abstract][Full Text] [Related]
3. MSMS reimbursement roundup.
Nurenberg J
Mich Med; 1992 Apr; 91(4):18-20. PubMed ID: 1614335
[No Abstract] [Full Text] [Related]
4. Reimbursement revolution. Medicare's RBRVS system.
Richardson M
Tex Med; 1992 Mar; 88(3):36-44. PubMed ID: 1574779
[No Abstract] [Full Text] [Related]
5. 15 steps to protect your practice from abusive payment practices.
Tenn Med; 2004 Nov; 97(11):512. PubMed ID: 15620209
[No Abstract] [Full Text] [Related]
6. United healthcare, five oncology practices try bundled payments.
Goozner M
J Natl Cancer Inst; 2011 Jan; 103(1):8-10. PubMed ID: 21169535
[No Abstract] [Full Text] [Related]
7. Increase in oral cancer drugs raises thorny issues for oncology practices.
Hede K
J Natl Cancer Inst; 2009 Nov; 101(22):1534-6. PubMed ID: 19880814
[No Abstract] [Full Text] [Related]
8. Federal government issues "workplan" detailing fraud and abuse initiatives aimed at physicians.
J Ky Med Assoc; 1998 Dec; 96(12):481-3. PubMed ID: 9879177
[No Abstract] [Full Text] [Related]
9. Elimination of consult codes in neuro-ophthalmology: another blow to our subspecialty?
Frohman L; Digre K
J Neuroophthalmol; 2010 Jun; 30(2):210-1. PubMed ID: 20523201
[No Abstract] [Full Text] [Related]
10. National Academy of Neuropsychology/Division 40 of the American Psychological Association Practice Survey of Clinical Neuropsychology in the United States. Part II: Reimbursement experiences, practice economics, billing practices, and incomes.
Sweet JJ; Peck EA; Abramowitz C; Etzweiler S
Arch Clin Neuropsychol; 2003 Aug; 18(6):557-82. PubMed ID: 14591431
[TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
12. The adequacy of physician reimbursement for pediatric care under Medicaid.
McManus M; Flint S; Kelly R
Pediatrics; 1991 Jun; 87(6):909-20. PubMed ID: 2034498
[TBL] [Abstract][Full Text] [Related]
13. Commentary on the reimbursement paradox.
Reaven NL; Rosenbloom J
Crit Care Med; 2009 Jul; 37(7 Suppl):S285-9. PubMed ID: 19535960
[TBL] [Abstract][Full Text] [Related]
14. Staying ahead financially. Reimbursement tips for a changing environment.
Kondek D
Mich Med; 1998 Mar; 97(3):24-30. PubMed ID: 9542382
[TBL] [Abstract][Full Text] [Related]
15. Medicare update: what the latest changes will mean for you.
Henley E
J Fam Pract; 2007 Apr; 56(4):E1-3. PubMed ID: 17403321
[No Abstract] [Full Text] [Related]
16. Physician behavior impact when revenue shifted from drugs to services.
Feinberg B; Milligan S; Olson T; Wong W; Winn D; Trehan R; Scott J
Am J Manag Care; 2014 Apr; 20(4):303-10. PubMed ID: 24884861
[TBL] [Abstract][Full Text] [Related]
17. Keynote comment: Cancer drug pricing in the USA.
Johnson DH
Lancet Oncol; 2006 Jun; 7(6):444-5. PubMed ID: 16750490
[No Abstract] [Full Text] [Related]
18. How reimbursement affects medical practice.
Amerling R
Nephrol News Issues; 2005 Oct; 19(11):52-4, 63. PubMed ID: 16270735
[No Abstract] [Full Text] [Related]
19. Reimbursement: current status and future outlook.
Bailes JS
Semin Oncol; 1994 Aug; 21(4 Suppl 7):118-22. PubMed ID: 8091237
[TBL] [Abstract][Full Text] [Related]
20. Financing of physician ventures.
DeNelsky S
Iowa Med; 1995 May; 85(5):202-5. PubMed ID: 7607830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
